I82.529

Clinical Causes: Deep vein thrombosis (DVT) that persists or recurs in the iliac vein Blood clot formation due to stasis or slow blood flow in the veins Injury to the iliac vein from trauma or surgery Conditions that make blood more prone to clotting, such as certain genetic or acquired disorders Prolonged periods of immobility, such as long flights or bed rest Cancer or malignancies that increase clotting risk Pregnancy, due to increased blood volume and hormonal changes Obstructions or narrowing within the iliac vein, such as from tumors or swelling

Key Symptoms: Pain or tenderness in the pelvis or lower abdomen Swelling in the leg or groin area Discoloration of the skin, often a bluish or reddish hue Feeling of heaviness or discomfort in the affected limb Sensations of warmth or increased temperature in the area Reduced mobility or difficulty walking in some cases Possible signs of pulmonary embolism if part of the clot dislodges and reaches the lungs (such as sudden shortness of breath or chest pain)

Diagnosis Path: Diagnosis involves a combination of medical history review, physical examination, and imaging tests. Key diagnostic methods include: - Doppler ultrasound to evaluate blood flow and detect clots - Venography, where contrast dye is injected to visualize the veins - Magnetic Resonance Angiography (MRA) for detailed images of blood vessels - Computed Tomography Angiography (CTA) as an alternative imaging modality Laboratory tests may also be conducted to check for underlying clotting disorders or related issues.

Treatment Protocols: Treatment strategies aim to prevent clot growth, reduce symptoms, and prevent complications. Common approaches include: - Anticoagulant medications (blood thinners) to prevent clot extension and new clot formation - Thrombolytic therapy in select cases to dissolve existing clots - Compression therapy to improve blood flow and reduce swelling - Surgical interventions or catheter-based procedures to remove or bypass clots if necessary - Managing underlying risk factors, such as hormonal therapies or lifestyle modifications Close monitoring and follow-up are essential to ensure effective management and reduce risks of recurrent clots or other complications.